He told Medical News Today that: The meaning of relative risk is the risk compared to someone not taking the medication 31% is very low and indicates that the risk of developing thyroid cancer due to this medication is relatively low. Nevertheless, [c]aution still needs to be taken in patients who fall into the category of hereditary thyroid cancers like multiple endocrine neoplasia syndromes, he added
Lingvay I, Benamar M, Chen L, Fu A, Jdar E, Nishida T, Riveline JP, Yabe D, Zueger T, Ra R
It is a receptor for sterols and secosteroids
These studies would have investigated the drug's efficacy in lowering blood glucose, its effects on weight, and its safety profile
Cost remains a primary driver in employer decisions around GLP-1 coverage, Held said
Findings in animal studies don't always translate to humans, but these drugs are contraindicated (not recommended) for those with a family history of medullary thyroid carcinoma (MTC)